{"id":"a-novel-hgiia-vimentin-inhibitor","phase":"phase_1","safety":{"commonSideEffects":[]},"status":"active","trials":["NCT06926075"],"aliases":[],"patents":[],"pricing":[],"timeline":[],"aiSummary":"Inhibits hGIIA-Vimentin interaction Used for Treatment of various cancers.","brandName":"A novel hGIIA-Vimentin Inhibitor","companyId":"filamon-ltd","mechanism":{"_ai_source":"groq-llama-8b","explanation":"This interaction is involved in various cellular processes, and its inhibition may have therapeutic effects.","oneSentence":"Inhibits hGIIA-Vimentin interaction","_ai_confidence":"medium"},"commercial":null,"companyName":"Filamon LTD","competitors":[],"genericName":"A novel hGIIA-Vimentin Inhibitor","indications":{"approved":[{"name":"Treatment of various cancers"}]},"labelChanges":[],"trialDetails":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"rwe":[],"genericFilers":[],"relatedDrugs":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}